1. Estimated Market Size 2006 (US$M)$503 5-Year CAGR (Taka Base)9.27% 5-Year CAGR (US $ Base)4.50% Bangladesh Pharmaceutical Market

2. Key Features 97% of Demand Manufactured Locally 75% of Market Accounted by Retail Fledgling Exports (62 Countries) Low Price Market Branded Generic 28% of APIs Produced Locally

3. The Operators Local Companies96 MNCs with Mfg. Facilities6 MNCs w/o Mfg. Facilities3 Import Only45 150 Most Companies Vertically Integrated (Manufacturing, Marketing, and Distribution)

4. Industry Evolution Share of Top 4 Companies

5. Industry Evolution Share of Top 10 Companies

6. Industry Evolution Share of Top 20 Companies

7. Market Share of MNCs Local companies coming out on top

8. TypeListings TypeListings 1 Square LocalDSE, CSE11 GSK MNCDSE 2 Beximco LocalDSE, CSE, LSE12 Opsonin Local 3 Acme Local13 Novartis MNC 4 Incepta Local14 Orion Local 5 Eskayef Local15 Nuvista Local 6 Aventis MNC16 Healthcare Local 7 Renata LocalDSE17 Ibn Sina Local 8 Drug International Local18 Novo Nordisk MNC 9 ACI LocalDSE19 Roche MNC 10 Aristopharma Local20 Bio-Pharma Local The Top 20 (Based on Jan-Apr 07 Sales)

9. Investment Opportunities TRIPS 2016 THE BANGLADESH ADVANTAGE WHAT CAN YOU DO Patented APIs Biogenerics Cost Manufacture for Exports Formulation Expertise Product Development CRO

10. Talent in Bangladesh The Pharmaceutical Industry is the Largest Employer of White-Collar Workers Professionally Run Companies with a Global Mind-Set World-Class Manufacturing Facilities Two companies have recently been inspected by the UK MHRA, and are in the process of getting approved. 7 companies preparing for inspection by USFDA, MHRA, and TGA